SUESS MicroTec SE
XETRA:SMHN

Watchlist Manager
SUESS MicroTec SE Logo
SUESS MicroTec SE
XETRA:SMHN
Watchlist
Price: 49.85 EUR -0.3%
Market Cap: 952.9m EUR
Have any thoughts about
SUESS MicroTec SE?
Write Note

SUESS MicroTec SE
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SUESS MicroTec SE
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
SUESS MicroTec SE
XETRA:SMHN
Total Liabilities & Equity
€474.3m
CAGR 3-Years
22%
CAGR 5-Years
19%
CAGR 10-Years
11%
PVA TePla AG
XETRA:TPE
Total Liabilities & Equity
€311.1m
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
13%
Siltronic AG
XETRA:WAF
Total Liabilities & Equity
€4.6B
CAGR 3-Years
29%
CAGR 5-Years
19%
CAGR 10-Years
17%
Aixtron SE
XETRA:AIXA
Total Liabilities & Equity
€1B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
7%
SMA Solar Technology AG
XETRA:S92
Total Liabilities & Equity
€1.7B
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
3%
Centrotherm International AG
F:CTNK
Total Liabilities & Equity
€403.2m
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

SUESS MicroTec SE
Glance View

Market Cap
952.9m EUR
Industry
Semiconductors

The company is headquartered in Garching, Bayern and currently employs 1,178 full-time employees.

SMHN Intrinsic Value
51.15 EUR
Undervaluation 3%
Intrinsic Value
Price

See Also

What is SUESS MicroTec SE's Total Liabilities & Equity?
Total Liabilities & Equity
474.3m EUR

Based on the financial report for Sep 30, 2024, SUESS MicroTec SE's Total Liabilities & Equity amounts to 474.3m EUR.

What is SUESS MicroTec SE's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
11%

Over the last year, the Total Liabilities & Equity growth was 32%. The average annual Total Liabilities & Equity growth rates for SUESS MicroTec SE have been 22% over the past three years , 19% over the past five years , and 11% over the past ten years .

Back to Top